None listed
Conditions
Interventions
Intervention1: Oral Vitamin B12 tablets 1000 microgram each: commercially available over the counter Vitamin B12 tablets marketed as food supplements and available all over the world as food supplemen
Sponsors
ICMR DHR
Eligibility
Inclusion criteria
Inclusion criteria: Only the married, non-pregnant females who are planning a pregnancy and willing to take drugs as required in the intervention arm or control arm for treatment of anemia will be recruited.
Exclusion criteria
Exclusion criteria: Those reproductive age group females, who are using any mode of contraception, or in lactational amenorrhea, or are diagnosed as infertile, will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The outcome measure will be Adverse Pregnancy Outcomes which will include any one of the following: Adverse Events (AE) o Infertility o Preterm delivery o Intrauterine growth retardation o Intrauterine growth retardation o Neonatal complications requiring admission in hospital o Abortion or threatened abortion requiring treatment o Hyperemesis gravidarum requiring treatment o Gestational Diabetes o Gestational HTN/Preeclampsia/ecclampsia/HELLP syndrome diagnosed by an obstetrician Timepoint: Each trimester of pregnancy At termination of pregnancy 1 month after delivery | — |
Secondary
| Measure | Time frame |
|---|---|
| noneTimepoint: none | — |
Countries
India
Contacts
Public ContactDr Vivek Chauhan
Dr. Rajendra Prasad Government Medical College Tanda, Kangra, HP
Outcome results
None listed